Connor, Clark & Lunn Investment Management (CC&L)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-316,502
| Closed | -$699K | – | 1617 |
|
|
2025
Q1 | $699K | Sell |
316,502
-131,492
| -29% | -$291K | ﹤0.01% | 1057 |
|
|
2024
Q4 | $2.44M | Buy |
447,994
+57,727
| +15% | +$315K | 0.01% | 669 |
|
|
2024
Q3 | $3.24M | Sell |
390,267
-60,195
| -13% | -$500K | 0.02% | 548 |
|
|
2024
Q2 | $3.23M | Buy |
450,462
+112,038
| +33% | +$802K | 0.01% | 536 |
|
|
2024
Q1 | $2.93M | Buy |
+338,424
| New | +$2.93M | 0.01% | 563 |
|